ADARx Pharmaceuticals files for Nasdaq Global Market IPO under ADRX
ADARx Pharmaceuticals, a late-clinical stage siRNA therapeutics developer, filed for an initial public offering and plans to list on the Nasdaq Global Market under ticker ADRX.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.